AMANDA REYNOLDS: Open Payments
NPI 1952785222 · CARTERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 104 payments from 21 companies in 2025. Trend: 2023 $1,813 · 2024 $1,622 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $274 |
| ABBVIE INC. | 13 | $205 |
| AstraZeneca Pharmaceuticals LP | 4 | $198 |
| GlaxoSmithKline, LLC. | 13 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $161 |
| Lilly USA, LLC | 9 | $129 |
| Viatris Specialty LLC | 6 | $118 |
| Dexcom, Inc. | 4 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $75 |
Products named: BREZTRI, JARDIANCE, Ozempic, MOUNJARO, TRELEGY ELLIPTA, YUPELRI, Dexcom G6 Transmitter, VRAYLAR.
Industry payments across IL — which companies pay providers there.
